| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |